Pfizer Appoints Cecile Guegan as Chief Financial Officer

Nov 3, 2026 11:51 AM

View all comments（0）



Pfizer Inc. announced the unanimous appointment of Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Guegan, who has served as interim CFO since August 16, 2026, will officially assume full responsibility for overseeing the company's comprehensive financial management, strategic planning, and operational execution moving forward.

AI-generated summary

Pfizer Inc. (NYSE: PFE) announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President. The appointment will take effect on November 1, 2026.

Guegan has served as Pfizer’s interim Chief Financial Officer since August 16, 2026. In that role, she has steered the company’s financial operations, execution and strategic planning.

As Chief Financial Officer and Executive Vice President, Guegan will oversee every aspect of Pfizer’s financial management.

This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

SpaceX, Tesla Merger Reportedly Could Be Announced as Soon as December, Potentially Ahead of Democrats Taking Control of Congress in January

According to Bloomberg, citing people familiar with the matter, merger talks between SpaceX (SPCX) and Tesla (TSLA) have progressed, with a deal potentially being announced as early as December, though an option to delay the announcement until early 2027 has also been discussed. Boards and advisors from both companies are currently in discussions regarding transaction terms, the combined company's governance structure, and other matters.

Gold Slumps 3% Below $3,900: What Is Causing the Continued Decline in Gold Prices?

On November 12, Eastern Time, spot gold (XAUUSD) dropped more than 3% intraday to $3,864 per ounce, hitting its lowest level since October of last year. Higher-than-expected U.S. inflation data, coupled with successive hawkish signals from Federal Reserve officials, drove the U.S. dollar higher and kept investment demand for gold under sustained pressure.

Cisco Stock Retests $101.60 Ahead of Q1 Results, With AI Orders in Focus

TradingKey - CSCO rose 2.66% to $100.76 and now retests $101.60, the support it lost in early November, as Q1 results after the close put AI orders and margins in focus.

SanDisk Stock Price Forecast: Oversold Rebound Drives 14% Rally, Break Above $1,000 Could Spark Another 14% Gain

TradingKey - SanDisk (SNDK) shares rose 13.7% on Wednesday to close at around $983. The stock is poised to advance toward the 38.2% retracement level at $1,144, representing approximately 14% potential upside from the $1,000 mark.

US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?

TradingKey - On Friday (November 13) Eastern Time, the U.S. will release the October Producer Price Index (PPI). Following October's CPI once again exceeding expectations, the market will look to the PPI to further assess whether price pressures on the U.S. production side are spreading, as well as the likelihood of the Federal Reserve raising interest rates by 25 basis points or 50 basis points in December.

Featured Tools